Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GX-E2 Dose Finding and Safety in Anemic CKD Patients on Dialysis
NCT02044653Phase 2Completed
- Sponsor
- Genexine
- Start
- Apr 2014
- Primary completion
- Apr 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of efepoetin alfa in anemia, sponsored by Genexine. Started Apr 2014; status: completed.
02
Drugs
efepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02044653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044653.